background image

Paid Clinical Trials Billings

Discover 118 paid clinical trials in Billings, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Billings MT, Las Vegas NV, Walnut Creek CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05139017

Phase2, Phase3, Recruiting
Active & Responsive

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for
Breast Neoplasms, Breast Cancer
Location: Billings MT, Tigard OR, Santa Monica CA, Skokie IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06797635

Phase2, Recruiting
Active & Responsive

A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)

for
Gastrointestinal Cancer
Location: Billings MT, Madison WI, Cleveland OH, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06864169

Phase2, Recruiting
Active & Responsive

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Billings MT, Portland OR, Omaha NE, Saint Louis Park MN,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase1, Phase2, Recruiting
Active & Responsive

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

for
Recurrent Endometrial Carcinoma,
Location: Billings MT, Bozeman MT, Great Falls MT, Anaconda MT,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05554328

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: Billings MT, Sheridan WY, Bozeman MT, Great Falls MT,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase3, Recruiting
Active & Responsive

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

for
Plantar Fibromatosis, Ledderhose Disease
Location: Billings MT, Missoula MT, Bountiful UT,
Sponsor: Endo Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06151197

Phase3, Recruiting
Active & Responsive

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for
Prostate Cancer, Prostatic Neoplasms
Location: Billings MT, Grand Island NE, Omaha NE,
Sponsor: Merck Sharp & Dohme LLC

Sex: Male

Age: 18+

Code: NCT06925737

Phase3, Recruiting
Active & Responsive

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for
Breast Carcinoma, Colorectal Carcinoma,
Location: Billings MT, Bozeman MT, Great Falls MT, Havre MT,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06418204

Recruiting
Active & Responsive

National Cancer Institute "Cancer Moonshot Biobank"

for
Acute Myeloid Leukemia,
Location: Billings MT, Butte MT, Lafayette CO, Brighton CO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 13+

Code: NCT04314401

Recruiting